BELLUS Health Income Statement 2022-2011 | BLU

Brief overview of income trends at BELLUS Health

This overview is based on financial performance over the past five years. Revenue reported by BELLUS Health was 131 thousand dollars at the beginning of the period and 16 thousand dollars at the end. The five-year change reached −87.8%, while CAGR stood at −34.4%. The business finished the period with a smaller revenue base.

EBITDA was −4.5 million dollars at the beginning and −77.9 million dollars at the end of the period (−1647.3%). Changes in revenue did not translate into comparable EBITDA performance. At the operating-margin level, the figure shifted from −3397% to −486768.8%. Cost pressure reduced operating profitability.

Net income moved from −1.5 million dollars at the start to −76.1 million dollars at the end. The period ended with a larger loss than it began with.

Market value was $23 million at the start and $1.7 billion at the end. The higher valuation contrasts with weaker financial performance.

Summary assessment

The financial trajectory is weak and requires a cautious interpretation. The overall view is constrained by a narrow EBITDA buffer, pressure on operating profitability and weak sales momentum. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.